192 related articles for article (PubMed ID: 38478333)
1. Immunohistochemistry for Cancer Stem Cell Detection: Principles and Methods.
Zannini G; Franco R; Zito Marino F
Methods Mol Biol; 2024; 2777():19-33. PubMed ID: 38478333
[TBL] [Abstract][Full Text] [Related]
2. Immunohistochemistry for Cancer Stem Cells Detection: Principles and Methods.
Intartaglia M; Sabetta R; Gargiulo M; Roncador G; Marino FZ; Franco R
Methods Mol Biol; 2018; 1692():195-211. PubMed ID: 28986898
[TBL] [Abstract][Full Text] [Related]
3. Surface markers of cancer stem cells in solid tumors.
Xia P
Curr Stem Cell Res Ther; 2014 Mar; 9(2):102-11. PubMed ID: 24359139
[TBL] [Abstract][Full Text] [Related]
4. Cancer stem cells.
Yu Z; Pestell TG; Lisanti MP; Pestell RG
Int J Biochem Cell Biol; 2012 Dec; 44(12):2144-51. PubMed ID: 22981632
[TBL] [Abstract][Full Text] [Related]
5. Stem cell programs in cancer initiation, progression, and therapy resistance.
Huang T; Song X; Xu D; Tiek D; Goenka A; Wu B; Sastry N; Hu B; Cheng SY
Theranostics; 2020; 10(19):8721-8743. PubMed ID: 32754274
[TBL] [Abstract][Full Text] [Related]
6. The utility of CD44, CD117 and CD133 in identification of cancer stem cells (CSC) in oral squamous cell carcinomas (OSCC).
Mărgăritescu C; Pirici D; Simionescu C; Stepan A
Rom J Morphol Embryol; 2011; 52(3 Suppl):985-93. PubMed ID: 22119814
[TBL] [Abstract][Full Text] [Related]
7. Cancer stem cells (CSCs) in cancer progression and therapy.
Najafi M; Farhood B; Mortezaee K
J Cell Physiol; 2019 Jun; 234(6):8381-8395. PubMed ID: 30417375
[TBL] [Abstract][Full Text] [Related]
8. Proline-Rich Protein 11 Regulates Self-Renewal and Tumorigenicity of Gastric Cancer Stem Cells.
Hu H; Song Z; Yao Q; Geng X; Jiang L; Guo C; Li H
Cell Physiol Biochem; 2018; 47(4):1721-1728. PubMed ID: 30007956
[TBL] [Abstract][Full Text] [Related]
9. Cell plasticity, senescence, and quiescence in cancer stem cells: Biological and therapeutic implications.
Paul R; Dorsey JF; Fan Y
Pharmacol Ther; 2022 Mar; 231():107985. PubMed ID: 34480963
[TBL] [Abstract][Full Text] [Related]
10. Differentiation therapy: targeting human renal cancer stem cells with interleukin 15.
Azzi S; Bruno S; Giron-Michel J; Clay D; Devocelle A; Croce M; Ferrini S; Chouaib S; Vazquez A; Charpentier B; Camussi G; Azzarone B; Eid P
J Natl Cancer Inst; 2011 Dec; 103(24):1884-98. PubMed ID: 22043039
[TBL] [Abstract][Full Text] [Related]
11. Drug Resistance Driven by Cancer Stem Cells and Their Niche.
Prieto-Vila M; Takahashi RU; Usuba W; Kohama I; Ochiya T
Int J Mol Sci; 2017 Dec; 18(12):. PubMed ID: 29194401
[TBL] [Abstract][Full Text] [Related]
12. Cancer Stem Cells and Their Therapeutic Usage.
Osum M; Kalkan R
Adv Exp Med Biol; 2023; 1436():69-85. PubMed ID: 36689167
[TBL] [Abstract][Full Text] [Related]
13. Targeting cancer stem cell-specific markers and/or associated signaling pathways for overcoming cancer drug resistance.
Ranji P; Salmani Kesejini T; Saeedikhoo S; Alizadeh AM
Tumour Biol; 2016 Oct; 37(10):13059-13075. PubMed ID: 27561758
[TBL] [Abstract][Full Text] [Related]
14. Spheroid-Formation (Colonosphere) Assay for in Vitro Assessment and Expansion of Stem Cells in Colon Cancer.
Shaheen S; Ahmed M; Lorenzi F; Nateri AS
Stem Cell Rev Rep; 2016 Aug; 12(4):492-9. PubMed ID: 27207017
[TBL] [Abstract][Full Text] [Related]
15. Distinct populations of tumor-initiating cells derived from a tumor generated by rat mammary cancer stem cells.
Zucchi I; Astigiano S; Bertalot G; Sanzone S; Cocola C; Pelucchi P; Bertoli G; Stehling M; Barbieri O; Albertini A; Schöler HR; Neel BG; Reinbold RA; Dulbecco R
Proc Natl Acad Sci U S A; 2008 Nov; 105(44):16940-5. PubMed ID: 18957543
[TBL] [Abstract][Full Text] [Related]
16. Cancer Stem Cells and Stem Cell Tumors in Drosophila.
Singh SR; Aggarwal P; Hou SX
Adv Exp Med Biol; 2019; 1167():175-190. PubMed ID: 31520355
[TBL] [Abstract][Full Text] [Related]
17. Characterization of cancer stem cells from different grades of human colorectal cancer.
Manhas J; Bhattacharya A; Agrawal SK; Gupta B; Das P; Deo SV; Pal S; Sen S
Tumour Biol; 2016 Oct; 37(10):14069-14081. PubMed ID: 27507615
[TBL] [Abstract][Full Text] [Related]
18. Cancer stem cell heterogeneity: origin and new perspectives on CSC targeting.
Eun K; Ham SW; Kim H
BMB Rep; 2017 Mar; 50(3):117-125. PubMed ID: 27998397
[TBL] [Abstract][Full Text] [Related]
19. Cancer stem cell differentiation: TGFβ1 and versican may trigger molecules for the organization of tumor spheroids.
Oktem G; Sercan O; Guven U; Uslu R; Uysal A; Goksel G; Ayla S; Bilir A
Oncol Rep; 2014 Aug; 32(2):641-9. PubMed ID: 24927163
[TBL] [Abstract][Full Text] [Related]
20. The origin of cancer stem cells.
Bu Y; Cao D
Front Biosci (Schol Ed); 2012 Jan; 4(3):819-30. PubMed ID: 22202093
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
